Inhibition of Bcr serine kinase by tyrosine phosphorylation

Molecular and Cellular Biology

Volumn 16, Issue 3, 1996, Pages 998-1005

  Liu, Jiaxin ^a   Wu, Yun ^a   Ma, Guo Zhen ^a   Lu, Dai ^a   Haataja, Leena ^b   Heisterkamp, Nora ^b   Groffen, John ^b   Arlinghaus, Ralph B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN SERINE KINASE; TYROSINE;

ANIMAL CELL; ARTICLE; CHRONIC MYELOID LEUKEMIA; EXON; GENE FUSION; GENE SEQUENCE; NONHUMAN; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANIMALIA;

EID: 0030067346     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.16.3.998     Document Type: Article

References (28)

1. Afar, D. E. H., A. Goga, J. McLaughlin, O. N. Witte, C. L. Sawyers. 1994. Differential complementation of Bcr-Abl point mutants with c-Myc. Science 264:424-426.
2. Annamalai, A. E., and R. F. Colman. 1981. Reaction of the adenine nucleotide analogue 5′-p-fluorosulfonylbenzoyl adenosine at distinct tyrosine and cysteine residues of rabbit muscle pyruvate kinase. J. Biol. Chem. 256:10276-10283.
3. Boyle, W. J., P. Van der Geer, and T. Hunter. 1991 Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol. 201:110-149.
4. Campbell, M., W. Li, and R. B. Arlinghaus. 1990. P210 BCR-ABL is complexed to P160 BCR and ph-P53 proteins in K562 cells. Oncogene 5:773-776.
5. Campbell, M. L., and R. B. Arlinghaus. 1991. Current status of the BCR gene and its involvement with human leukemia. Adv Cancer Res. 57:227-256.
6. c-src during fibroblast mitosis. Cell 52:801-810.
7. bcr-abl gene of the Philadelphia chromosome. Science 247:824-830.
8. Deng, W. P., and J. A. Nickoloff. 1992. Site-directed mutagenesis of virtually any plasmid by eliminating a unique site. Anal. Biochem. 200:81-88.
9. Gale, N. W., S. Kaplan, E. J. Lowenstein, J. Schlessinger, and D. Bar-Sagi. 1993. Grb2 mediates the EGF-dependeat activation of guanine nucleotide exchange on Ras. Nature (London) 363:88-92.
10. Heisterkamp, N., G. Jenster, J. ten Hoeve, D. Zovich, P. K. Pattengale, and J. Groffen. 1990. Acute leukemia in BCR-ABL transgenic mice. Nature (London) 344:251-253
11. Hunter, T., and J. A. Cooper. 1986. Viral oncogenes and tyrosine phosphorylation. Enzymes 17:191-246.
12. Hunter, T., and B. Sefton. 1980. Transforming gene product of Rous sarcoma virus phosphorylates tyrosine. Proc. Natl. Acad. Sci. USA 77:1311-1315.
13. Kloetzer, W., R. Kurzrock, L. Smith, M. Talpaz, M. Spiller, J. Gutterman, and R. B. Arlinghaus. 1985. The human cellular abl gene product in the chronic myelogenous leukemia. Virology 140:230-238.
14. Konopka, J. B., S. M. Watanabe, and O. N. Witte. 1984. An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell 37:1035-1042.
15. Li, W., O. Dreazen, W. Kloetzer, R. P. Gale, and R. B. Arlinghaus. 1989. Characterization of bcr gene products in hematopoietic cells. Oncogene 4:127-138.
16. Liu, J., M. Campbell, J. G. Guo, D. Lu, Y. M. Xian, B. S. Andersson, and R. B. Arlinghaus. 1993. Bcr-Abl tyrosine kinase is autophosphorylated or transphosphorylates P160 BCR on tyrosine predominantly within the first BCR exon. Oncogene 8:101-109.
17. Lu, D., J. Liu, M. Campbell, J. G. Guo, N. Heisterkamp, J. Groffen, E. Cannani, and R. B. Arlinghaus. 1993. Tyrosine phosphorylation of P160 BCR by P145 c-ABL and P210 BCR-ABL. Blood 82:1257-1260.
18. Maru, Y., K. L. Peters, D. E. H. Afar, M. Shibuya, O. N. Witte, and T. E. Smithgall. 1995. Tyrosine phosphorylation of BCR by FPS/FES protein-tyrosine kinases induces association of BCR with GRB-2/SOS. Mol. Cell. Biol. 15:835-842.
19. Maru, Y., and O. N. Witte. 1991. The BCR gene encodes a novel serine/ threonine kinase activity within a single exon. Cell 67:459-468.
20. McWhirter, J. R., and J. Y. J. Wang. 1991. Activation of tyrosine kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins. Mol. Cell. Biol 11:1553-1565.
21. cdc2 protein kinase in vertebrates. EMBO J. 10:3321-3329.
22. Pendergast, A. M., M. L. Gishizky, M. H. Havlik, and O. N. Witte. 1993. SH1 domain autophosphorylation of P210 BCR/ABL is required for transformation but not growth factor independence. Mol. Cell. Biol. 13:1728-1736.
23. Pendergast, A. M., L. A. Quilliam, L. D. Cripe, C. H. Bassing, Z. Dai, N. Li, A. Batzer, K. M. Rabun, C. J. Der, J. Schlessinger, and M. L. Gishizky. 1993. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB2 adaptor protein. Cell 75:175-185.
24. Puil, L., J. Liu, G. Gish, G. Mbamalu, D. Bowtell, P. G. Pelicci, R. Arlinghaus, and T. Pawson. 1994. BCR-ABL oncoproteins bind directly to activators of the Ras signalling pathway. EMBO J. 13:764-773.
25. Shtivelman, E., B. Lifshitz, R. P. Gale, and E. Canaani. 1985. Fused transcript of abl and bcr genes in chronic myelogenous leukemia. Nature (London) 315:550-554.
26. Stam, K., N. Heisterkamp, G. Grosveld, A. de Klein, R. S. Verma, M. Coleman, H. Dosik, and J. Groffen. 1985. Evidence of a new chimeric bcr/c-abl mRNA in patients with chronic myelocytic leukemia and the Philadelphia chromosome. N. Engl. J. Med. 313:1429-1433
27. Stam, K., N. Heisterkamp, F. H. Reynolds, Jr., and J. Groffen. 1987. Evidence that the phl gene encodes a 160,000-dalton phosphoprotein with associated kinase activity. Mol. Cell. Biol 7:1955-1960.
28. Sullivan, S., and T. W. Wong. 1991. A manual sequencing method for identification of phosphorylated ammo acids in phosphopeptides. Anal. Biochem. 197:65-68.